@misc{indiciae2dc890d23e79,
  title = {Real-world frontline treatments in patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor exon 20 insertions and adjusted comparisons versus amivantamab plus chemotherapy from the PAPILLON study.},
  author = {Christos Chouaid and Lise Bosquet and Craig Knott and Ziming Li and Marcy Schaeffer and Xiwu Lin and Claudio A Schioppa and Nolen Joy Perualila and Joris Diels and Eduardo Quintero Caparros and Francesca Galea and Annika Hult\&\#xe9;n and Alastair Greystoke},
  year = {2025},
  doi = {10.1016/j.lungcan.2025.108548},
  url = {https://pubmed.ncbi.nlm.nih.gov/40262227/},
  note = {Source identifier: 40262227}
}